Thursday, December 06, 2018 2:42:19 PM
"Apple got a first-of-its-kind clearance for its electrocardiogram app from federal regulators in September after conducting a preclinical study with 2,000 people. It also did a clinical trial with 600 other participants to ensure it could distinguish between a normal heartbeat, or sinus rhythm, and atrial fibrillation."
https://www.cnbc.com/2018/12/06/apple-watch-ecg-sensor-review.html
https://www.apple.com/healthcare/site/docs/Apple_Watch_Arrhythmia_Detection.pdf
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM